JPM _ US Healthcare_ Biotech Team Call 11am ET, EWTX Deep Dive, ALNY Recap, ZTS, DXCM, AMPH, OGN, DOCS, PACB, ORIC Mgmt Call. Fri Feb 14 2025

Elif Korkmaz - Specialist Sales - US Healthcare AC elif.korkmaz@jpmchase.com J.P. Morgan Securities LLC North America Specialist Sales J P M O R G A N 14 February 2025 MRNA: 4Q revs largely in line with what they pre-announced at our conference. 4Q R&D expenses $1.12bn vs cons$1.17bn. Reiterated 2025 topline guidance of $1.5-$2.5bn, most all of it in 2H25 due to seasonality. Looks like noro is on clinical hold following a single case of GBS. Call 8am ET Key Highlights Large Cap BioTech US Large Cap Biotech ...